Benzodiazepine use among young attendees of an Irish substance treatment center
dc.contributor.author | Murphy, Kevin D. | |
dc.contributor.author | Byrne, Stephen | |
dc.contributor.author | McCarthy, Suzanne | |
dc.contributor.author | Lambert, Sharon | |
dc.contributor.author | Sahm, Laura J. | |
dc.date.accessioned | 2018-05-23T11:22:47Z | |
dc.date.available | 2018-05-23T11:22:47Z | |
dc.date.issued | 2014-05 | |
dc.date.updated | 2018-05-23T08:57:16Z | |
dc.description.abstract | Objective: To describe the demographic characteristics of those service users attending Matt Talbot Services, and their current and past substance use, and to explore the use of benzodiazepines among this group. Method: There were 198 service users who attended a substance misuse treatment center in Cork, Ireland, between January 2005 and August 2011. Results: Benzodiazepines had ever been used by 51.0%, and of these, 55.8% were regular benzodiazepine users. The mean age of first use was 14.9 ± 1.4 years. Regular users of benzodiazepines were regular users of significantly more substances (3, interquartile range [IQR] = 2-3) when compared with nonregular benzodiazepine users (1, IQR = 1-2). Regular benzodiazepine users showed more behavioral signs (12, IQR = 10-14) than nonregular users (9, IQR = 7-12). Physical signs were significantly different between regular (8, IQR = 6-11) and nonregular (5, IQR = 3-10) users. Conclusions: The effects of benzodiazepine misuse affect the individual, their family, and society as a whole through hospitalization, substance treatment, and crime. Identifying regular benzodiazepine users can help reduce the burden of benzodiazepines. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Murphy, K. D., Byrne, S., McCarthy, S., Lambert, S. and Sahm, L. J. (2014) 'Benzodiazepine Use Among Young Attendees of an Irish Substance Treatment Center', Journal of Addiction Medicine, 8(3), pp. 199-204. doi: 10.1097/ADM.0000000000000025 | en |
dc.identifier.doi | 10.1097/ADM.0000000000000025 | |
dc.identifier.endpage | 204 | en |
dc.identifier.issn | 1932-0620 | |
dc.identifier.journaltitle | Journal Of Addiction Medicine | en |
dc.identifier.startpage | 199 | en |
dc.identifier.uri | https://hdl.handle.net/10468/6178 | |
dc.identifier.volume | 8 | en |
dc.language.iso | en | en |
dc.publisher | Lippincott, Williams & Wilkins | en |
dc.relation.uri | https://journals.lww.com/journaladdictionmedicine/Fulltext/2014/05000/Benzodiazepine_Use_Among_Young_Attendees_of_an.8.aspx | |
dc.rights | © 2014 American Society of Addiction Medicine. This is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Addiction Medicine, doi: 10.1097/ADM.0000000000000025 | en |
dc.subject | Benzodiazepines | en |
dc.subject | Ireland | en |
dc.subject | Treatment center | en |
dc.subject | Young people | en |
dc.subject | Metaanalysis | en |
dc.subject | Withdrawal | en |
dc.subject | Dementia | en |
dc.subject | Diazepam | en |
dc.subject | Risk | en |
dc.title | Benzodiazepine use among young attendees of an Irish substance treatment center | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- JAM-D-13-00108_(Resubmission)-Reposit.pdf
- Size:
- 2.37 MB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: